Lung cancer misdiagnosis claims

A clear chest X-ray does not rule out lung cancer. CT chest is the test NICE asks GPs to consider when a smoker or ex-smoker has a persistent cough, unexplained weight loss or blood in the sputum. Our lung cancer claims usually start with a CT scan that was never arranged.

By the time a CT scan was finally arranged, the cancer had grown, spread to lymph nodes, or reached the pleura or distant organs. Curative surgery was no longer on the table. The plan shifted to chemotherapy, immunotherapy and radiotherapy, and for some families to palliative care.

If that mirrors your experience, our medical negligence team can tell you whether the delay amounts to a claim. We will assess the records without obligation and act on a no win no fee basis. Our delayed cancer diagnosis work is recognised by Legal 500 2026 and Chambers UK 2026.

The CT scan your GP should have requested

NICE guideline NG12 is the standard your GP is measured against on suspected cancer referrals. For lung cancer, it sets out a clear two-week-wait CT chest pathway that is repeatedly missed in primary care.

An urgent chest X-ray is expected for anyone over 40 with persistent cough, fatigue, shortness of breath, chest pain, weight loss or appetite loss, particularly if they smoke or used to. A direct urgent referral on the suspected cancer pathway is expected if there is unexplained haemoptysis, which means coughing up blood, in anyone over 40. The same urgent route applies to a chest X-ray that suggests lung cancer.

A recurrent or persistent chest infection in a smoker or ex-smoker is not a reason to keep prescribing antibiotics. It is a reason to image the chest. A persistent cough lasting more than three weeks in someone with a smoking history is itself a referral trigger. Many of the claims we run start with three, four or five GP entries for the same symptom, none of which led to a CT.

Why a “clear” chest X-ray is not the end of the story

Plain chest X-rays miss a meaningful proportion of early lung cancers. Tumours behind the heart, in the apex of the lung, or smaller than around one centimetre are routinely invisible on X-ray but obvious on CT. A normal X-ray in a patient with red-flag symptoms is not a clean bill of health, and NICE expects clinicians to escalate to CT where the clinical picture continues to point at lung cancer despite a clear film.

We also see cases where the X-ray was not, in fact, clear. The British Thoracic Society guidance on the investigation of pulmonary nodules requires follow-up imaging at defined intervals depending on the size and appearance of the nodule. A small nodule reported on an X-ray or incidental CT and then never followed up is one of the most common patterns of negligence in this area. By the time the patient presents again with worsening symptoms, the nodule has become a stage 3 or stage 4 tumour.

When NHS targeted lung health checks should have caught it

The NHS Targeted Lung Health Check programme is now rolling out across England for people aged 55 to 74 with a history of smoking. Eligible patients are invited for a lung health assessment and, if their risk score is high enough, a low-dose CT scan designed to find lung cancer at stage 1, when it can still be cured.

We are starting to see claims where eligible patients were not invited, were invited but not followed up after a positive screening result, or had a screen-detected nodule that was then lost in the system between the screening hub and the local hospital. Where a screening programme exists to catch a cancer at stage 1 and the patient is instead diagnosed at stage 3 or 4, the case for breach of duty and causation is often a strong one.

What we have to prove for a lung cancer claim

A claim does not exist simply because something went wrong. We have to prove two things side by side.

The first is breach of duty. We have to show the care you received fell below what a reasonably competent GP, radiologist or respiratory physician would have provided. NICE NG12, the British Thoracic Society pulmonary nodule guidance and the Royal College of Radiologists reporting standards are the benchmarks. Repeated antibiotics for a smoker’s recurrent chest infection without imaging, haemoptysis that was not urgently referred, a peripheral lesion missed on a chest X-ray, a small nodule reported but never followed up, each of these is a recognised breach pattern.

The second is causation. Even where the care was poor, you only have a claim if earlier diagnosis would have changed your prognosis or treatment. This is where most lung cancer cases turn. We instruct independent respiratory physicians, thoracic surgeons and oncologists to compare what your treatment and outcome would have been at the missed appointment with what they are now. A delay that allows a stage 1 tumour, where curative surgery is possible and five-year survival sits around 60 to 70 per cent, to progress to stage 4, where five-year survival falls below 10 per cent, transforms the case from one that can win to one that has to.

How a late diagnosis narrows your treatment

Stage at diagnosis decides what treatment can do. Each month of delay closes off another choice.

Caught early at T1 or T2, lung cancer can often be removed by surgery, either an open lobectomy or a less invasive video-assisted thoracoscopic surgery (VATS) procedure. The intent is curative. Many patients return to normal life within months.

Caught late, surgery is no longer realistic. The plan becomes a combination of platinum-based chemotherapy, immunotherapy such as pembrolizumab, radiotherapy, and in some cases palliative care to manage breathlessness, pain and weight loss. Patients we represent describe the side effects of late-stage treatment, the fatigue, the neuropathy, the loss of lung function, the time spent in hospital rather than at home, as the daily cost of a diagnosis that should have arrived a year earlier.

For some patients the delay turns a survivable cancer into a fatal one. We act for families in fatal medical negligence claims where a partner, parent or sibling would still be alive had the chest X-ray, the CT or the two-week-wait referral happened when it should have.

Lung cancer compensation: what late-diagnosis settlements cover

Compensation in a lung cancer claim is calculated in two parts. General damages cover the pain, suffering and loss of amenity caused by the negligence. Special damages cover the financial losses that flow from it. In practice that includes loss of earnings where the delayed diagnosis has stopped you working or shortened your working life, the cost of private treatment, including immunotherapy not available locally on the NHS, that you would not have needed had the cancer been caught earlier, care, oxygen equipment and home adaptations needed because of advanced disease or treatment side effects, travel costs for hospital appointments and oncology visits, and future losses, including pension shortfall and dependency claims where the prognosis is poor or the patient has already died.

Our cancer misdiagnosis solicitors have recovered six-figure settlements in delayed cancer diagnosis claims. The figure in any individual case depends on the stage of cancer at the missed appointment, the stage at diagnosis, and the impact on the patient and family.

★★★★★

“Nicholas Leahy at Osbornes Law was a great help during a very difficult time for me and my family. He fought very hard for us and was always there for if we need advice. We as a family are happy with the compensation they managed to get for us.”

Speak to a lung cancer misdiagnosis lawyer today

If you believe your lung cancer, or that of a partner, parent or relative you have lost, was missed, misdiagnosed or diagnosed too late, our medical negligence lawyers will review the case in confidence and without obligation. You have three years from the date of the negligence, or the date you became aware that negligence may have caused harm, to bring a claim. In bereaved-family cases the three years usually runs from the date of death. We can advise on which date applies.

Call 020 7485 8811 or fill in the contact form below.